Literature DB >> 30505519

The need to move away from fecal transplant towards targeted, refined microbiome therapy.

Lindsey Russell1, Tanya Monaghan2,3, Dina Kao4.   

Abstract

Year:  2018        PMID： 30505519      PMCID： PMC6236173          DOI： 10.21037/jtd.2018.09.80

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.

Authors:  Anna M Seekatz; Casey M Theriot; Krishna Rao; Yu-Ming Chang; Alison E Freeman; John Y Kao; Vincent B Young
Journal:  Anaerobe       Date:  2018-04-12       Impact factor: 3.331

2.  Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy.

Authors:  Srishti Saha; Sahil Khanna
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.

Authors:  Stephan J Ott; Georg H Waetzig; Ateequr Rehman; Jacqueline Moltzau-Anderson; Richa Bharti; Juris A Grasis; Liam Cassidy; Andreas Tholey; Helmut Fickenscher; Dirk Seegert; Philip Rosenstiel; Stefan Schreiber
Journal:  Gastroenterology       Date:  2016-11-17       Impact factor: 22.682

Review 4.  Phage or foe: an insight into the impact of viral predation on microbial communities.

Authors:  Lucía Fernández; Ana Rodríguez; Pilar García
Journal:  ISME J       Date:  2018-01-25       Impact factor: 10.302

5.  Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system.

Authors:  Emma Meader; Melinda J Mayer; Dietmar Steverding; Simon R Carding; Arjan Narbad
Journal:  Anaerobe       Date:  2013-05-17       Impact factor: 3.331

6.  Antibiotic Treatments for Clostridium difficile Infection Are Associated with Distinct Bacterial and Fungal Community Structures.

Authors:  Regina Lamendella; Justin R Wright; Jada Hackman; Christopher McLimans; David R Toole; William Bernard Rubio; Rebecca Drucker; Hoi Tong Wong; Kate Sabey; John P Hegarty; David B Stewart
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

Review 7.  Stable core virome despite variable microbiome after fecal transfer.

Authors:  Felix Broecker; Giancarlo Russo; Jochen Klumpp; Karin Moelling
Journal:  Gut Microbes       Date:  2016-12-09

8.  Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome.

Authors:  Tao Zuo; Sunny H Wong; Kelvin Lam; Rashid Lui; Kitty Cheung; Whitney Tang; Jessica Y L Ching; Paul K S Chan; Martin C W Chan; Justin C Y Wu; Francis K L Chan; Jun Yu; Joseph J Y Sung; Siew C Ng
Journal:  Gut       Date:  2017-05-24       Impact factor: 23.059

9.  Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.

Authors:  Janet Y Nale; Tamsin A Redgwell; Andrew Millard; Martha R J Clokie
Journal:  Antibiotics (Basel)       Date:  2018-02-13

Review 10.  Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.

Authors:  Amoe Baktash; Elisabeth M Terveer; Romy D Zwittink; Bastian V H Hornung; Jeroen Corver; Ed J Kuijper; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.